Standard Chemical (Taiwan) Performance
| 1720 Stock | TWD 62.20 0.20 0.32% |
The entity has a beta of -0.0393, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Standard Chemical are expected to decrease at a much lower rate. During the bear market, Standard Chemical is likely to outperform the market. At this point, Standard Chemical has a negative expected return of -0.0531%. Please make sure to validate Standard Chemical's coefficient of variation, variance, and the relationship between the mean deviation and standard deviation , to decide if Standard Chemical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Standard Chemical Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Standard Chemical is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
| Begin Period Cash Flow | 1 B | |
| Total Cashflows From Investing Activities | 819.1 M |
Standard |
Standard Chemical Relative Risk vs. Return Landscape
If you would invest 6,430 in Standard Chemical Pharmaceutical on September 18, 2024 and sell it today you would lose (230.00) from holding Standard Chemical Pharmaceutical or give up 3.58% of portfolio value over 90 days. Standard Chemical Pharmaceutical is generating negative expected returns and assumes 0.9802% volatility on return distribution over the 90 days horizon. Simply put, 8% of stocks are less volatile than Standard, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Standard Chemical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Standard Chemical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Standard Chemical Pharmaceutical, and traders can use it to determine the average amount a Standard Chemical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0542
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 1720 |
Estimated Market Risk
| 0.98 actual daily | 8 92% of assets are more volatile |
Expected Return
| -0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Standard Chemical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Standard Chemical by adding Standard Chemical to a well-diversified portfolio.
Standard Chemical Fundamentals Growth
Standard Stock prices reflect investors' perceptions of the future prospects and financial health of Standard Chemical, and Standard Chemical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Standard Stock performance.
| Return On Equity | 0.19 | |||
| Return On Asset | 0.0711 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | 10.56 B | |||
| Shares Outstanding | 178.7 M | |||
| Price To Earning | 15.72 X | |||
| Price To Book | 2.40 X | |||
| Price To Sales | 1.90 X | |||
| Revenue | 4.6 B | |||
| EBITDA | 1.24 B | |||
| Cash And Equivalents | 1.55 B | |||
| Cash Per Share | 8.70 X | |||
| Total Debt | 50 M | |||
| Debt To Equity | 25.70 % | |||
| Book Value Per Share | 25.38 X | |||
| Cash Flow From Operations | 827.03 M | |||
| Earnings Per Share | 4.54 X | |||
| Total Asset | 10.1 B | |||
| Retained Earnings | 1.17 B | |||
| Current Asset | 2.6 B | |||
| Current Liabilities | 1.18 B | |||
About Standard Chemical Performance
Evaluating Standard Chemical's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Standard Chemical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Standard Chemical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Standard Chem Pharm CO., LTD. engages in the manufacture and sale of pharmaceutical products in Taiwan and internationally. The company was founded in 1967 and is headquartered in Tainan City, Taiwan. STANDARD CHEM operates under Drug Manufacturers - Specialty Generic classification in Taiwan and is traded on Taiwan Stock Exchange.Things to note about Standard Chemical performance evaluation
Checking the ongoing alerts about Standard Chemical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Standard Chemical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Standard Chemical generated a negative expected return over the last 90 days | |
| About 58.0% of the company shares are owned by insiders or employees |
- Analyzing Standard Chemical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Standard Chemical's stock is overvalued or undervalued compared to its peers.
- Examining Standard Chemical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Standard Chemical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Standard Chemical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Standard Chemical's stock. These opinions can provide insight into Standard Chemical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Standard Stock Analysis
When running Standard Chemical's price analysis, check to measure Standard Chemical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Standard Chemical is operating at the current time. Most of Standard Chemical's value examination focuses on studying past and present price action to predict the probability of Standard Chemical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Standard Chemical's price. Additionally, you may evaluate how the addition of Standard Chemical to your portfolios can decrease your overall portfolio volatility.